Keywords: Mercck & Co, AstrZeneca, Option agreement, Nexium, Prilosec

Merck & Co to continue posting sales and profits under AstraZeneca partnership

Article | 28 June 2012

Print This

US drug giant Merck & Co (NYSE: MRK) and Anglo-Swedish major AstraZeneca have amended the option agreement related to their ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in